Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Monitoring program finds serious, unreported adverse drug reactions

04.05.2005


A monitoring program developed by a Northwestern University researcher has successfully identified a large number of previously unknown, serious and often-fatal drug reactions associated with 15 commonly used drugs, including Plavix®, thalidomide and drug-coated cardiac stents.



As described in an article in the May 4 issue of the Journal of the American Medical Association, the Research on Adverse Drug Events and Reports (RADAR) Project compiles information from reports submitted to the U.S. Food and Drug Administration’s database and reports by drug companies and independent researchers throughout the world. RADAR is funded entirely by government grants.

RADAR has proved to be a powerful new instrument that supplements existing FDA surveillance systems and has helped save hundreds to thousands of patient lives, said lead author Charles L. Bennett, M.D., who directs the adverse drug reaction surveillance program. Bennett is professor of medicine in the division of hematology/oncology at Northwestern University Feinberg School of Medicine and a researcher at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, as well as a physician at the Jesse Brown Veterans Affairs Medical Center and associate director of the VA Mid-West Center for Health Services Research and Policy Studies. RADAR reviews have been published in leading medical journals. Summaries of the reviews have appeared in the media, and in "dear doctor" product warnings and labeling changes sent by pharmaceutical companies.


In the period between 1998 and 2004, Bennett and a multidisciplinary group of RADAR investigators identified serious adverse drug reactions with 14 commonly prescribed drugs, and with cardiac stents, that affected almost 1,700 patients, 170 of whom died as a result of the reaction. The drugs and devices are commonly used, with more than 1 million individuals have been prescribed two of the drugs.

Adverse drug reactions were classified as resulting in death, severe organ failure or requiring major therapeutic interventions, such as cardiopulmonary resuscitation, liver transplantation or placing an individual on a respirator. One particularly severe drug reaction with a novel cancer drug was associated with 67 deaths.

Adverse drug and device reactions account for as many as 100,000 deaths annually. In general, more than half of the most serious adverse drug reactions have been discovered seven or more years after a drug has been marketed.

The recent withdrawal of Vioxx has led to calls for new and independent postmarketing surveillance programs such as RADAR.

Elizabeth Crown | EurekAlert!
Further information:
http://www.northwestern.edu

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>